Rosacea is a chronic inflammatory skin condition that manifests as erythema, telangiectasia, papules, and pustules on the face. It primarily affects the cheeks, nose, chin, and forehead, causing flushing or transient erythema, persistent erythema, phymatous changes, papules, pustules, and telangiectasias. It can also manifest as ocular involvement. Rosacea affects women more frequently than men and can develop at any age. It has been observed to occur in individuals across a wide spectrum of skin types, including those classified as Fitzpatrick skin types 5 and 6. The physical changes associated with rosacea can result in social discomfort, potentially impacting the patient’s quality of life and self-perception. The etiology of rosacea is multifactorial, involving several potential triggers and the interaction of multiple pathophysiologic pathways, contributing to the clinical manifestations of this condition. Treatment aims to effectively address the symptoms manifesting in patients and to prevent disease progression. There are numerous treatment modalities available, which can be combined to address the various factors contributing to the condition. Treatment options include lifestyle modifications, topical agents, systemic medications, and light-based therapy. Maintaining the integrity of the skin barrier is imperative to ensure optimal treatment outcomes. The ideal approach entails meticulously customizing treatment regimens to align with the unique characteristics and preferences of each individual.